US20160283696A1 - Methods and device arrangement for physical activity thresholds promoting fat and cholesterol metabolism in high risk subjects - Google Patents
Methods and device arrangement for physical activity thresholds promoting fat and cholesterol metabolism in high risk subjects Download PDFInfo
- Publication number
- US20160283696A1 US20160283696A1 US15/034,185 US201415034185A US2016283696A1 US 20160283696 A1 US20160283696 A1 US 20160283696A1 US 201415034185 A US201415034185 A US 201415034185A US 2016283696 A1 US2016283696 A1 US 2016283696A1
- Authority
- US
- United States
- Prior art keywords
- acceleration
- physical activity
- maxima
- person
- cholesterol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000037081 physical activity Effects 0.000 title claims abstract description 65
- 238000000034 method Methods 0.000 title claims abstract description 20
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title claims description 54
- 230000004060 metabolic process Effects 0.000 title claims description 9
- 230000001737 promoting effect Effects 0.000 title description 3
- 235000000346 sugar Nutrition 0.000 claims abstract description 13
- 230000000694 effects Effects 0.000 claims abstract description 4
- 230000001133 acceleration Effects 0.000 claims description 40
- 239000008280 blood Substances 0.000 claims description 23
- 210000004369 blood Anatomy 0.000 claims description 23
- 235000012000 cholesterol Nutrition 0.000 claims description 14
- 210000001596 intra-abdominal fat Anatomy 0.000 claims description 14
- 150000003626 triacylglycerols Chemical class 0.000 claims description 12
- 230000000276 sedentary effect Effects 0.000 claims description 7
- 230000009286 beneficial effect Effects 0.000 claims description 4
- 230000007423 decrease Effects 0.000 claims description 4
- 150000001841 cholesterols Chemical class 0.000 claims description 3
- 235000019197 fats Nutrition 0.000 claims 4
- 238000004590 computer program Methods 0.000 claims 2
- 230000001413 cellular effect Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 18
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 17
- 206010033307 Overweight Diseases 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 208000008589 Obesity Diseases 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 4
- 235000020824 obesity Nutrition 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000035475 disorder Diseases 0.000 abstract 2
- 230000037356 lipid metabolism Effects 0.000 abstract 2
- 208000030159 metabolic disease Diseases 0.000 description 10
- 238000008214 LDL Cholesterol Methods 0.000 description 4
- 108010028554 LDL Cholesterol Proteins 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 208000001132 Osteoporosis Diseases 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 230000008821 health effect Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000013585 weight reducing agent Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000002308 calcification Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- G06F19/3481—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/1118—Determining activity level
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4866—Evaluating metabolism
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63B—APPARATUS FOR PHYSICAL TRAINING, GYMNASTICS, SWIMMING, CLIMBING, OR FENCING; BALL GAMES; TRAINING EQUIPMENT
- A63B69/00—Training appliances or apparatus for special sports
- A63B69/0028—Training appliances or apparatus for special sports for running, jogging or speed-walking
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/30—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0219—Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01P—MEASURING LINEAR OR ANGULAR SPEED, ACCELERATION, DECELERATION, OR SHOCK; INDICATING PRESENCE, ABSENCE, OR DIRECTION, OF MOVEMENT
- G01P15/00—Measuring acceleration; Measuring deceleration; Measuring shock, i.e. sudden change of acceleration
Definitions
- the invention relates to method and device for determining physical activity thresholds to improving sugar, cholesterol and fat metabolism in subjects who have sedentary life style.
- the use of motion sensors and transduction units to measure physical activity intensity and volume have been presented in U.S.2008/0312560A1, WO02005117703.
- a method in which physical activity improving cholesterol metabolism in healthy subjects is presented in U.S. 2010/0137107 A1.
- the invention described here belongs to the medical discipline and includes the determination of physical activity thresholds that can be used for preventing risks for metabolic diseases such as diabetes and cardiovascular disease by reducing blood cholesterol, triglycerides and visceral fat mass.
- the earlier invention purposed for healthy subjects related to physical activity reducing blood cholesterol (U.S. 2010/0137107 A1) is not suitable to subjects who have risks of diabetes and/or cardiovascular diseases, as they are not capable to perform prescribed physical activity previously shown to reduce blood cholesterol in healthy subjects (Herzig et al. 2014 Int J Obesity38:1089).
- Calcification of blood vessels, high blood sugar, cholesterol and triglycerides are risk factors for diabetes and cardiovascular diseases. These risk factors can be reduced by increased physical activity and weight reduction programs. Increased exercise will lead to decreases in blood LDL-cholesterol and increases HDL-cholesterol (tannescu et a. 2002 JAMA, 288,4994, Kraus et al. 2002, NEJM 347, 1483) all reducing risks of cardiovascular diseases. In a similar way increased weekly exercise and weight reduction programs prevented developing of the type 2 diabetes in 60% of patients (Tuomilehto et al. 2002,NEJM 304.1343, Knowler et al. 2002, NEJM 346:393).
- Fat tissues especially those around the internal organs are body's energy sources and are released to blood circulation during exercises. It has been shown that during exercises fat from the internal organs is first mobilized and starts the reduction of body weight (O'Leary et al. 2009, J Appl Physiol 100,1958).
- the invention described here manages physical activity thresholds reducing blood cholesterol, triglycerides and visceral fat in overweight subjects with metabolic disorders. These subjects are not able to reach physical activity thresholds presented in the patent (U.S. 20107137107), and therefore they need their own physical activity thresholds.
- the patents U.S. 2008/0312560 A1 and U.S. 2010/137107 A1 and the one described here belong to the same patents family, in which determining of physical activity thresholds are novel and differ from the previously known techniques
- Accelerometers (patents U.S. 2010191155 A1, EP 0700661 A2, U.S. 2009171614 A1, EP 2210557 A1 and U.S. 2001049470 A1) and a heart rate monitor (U.S. 20110213) have been previously used for measuring energy expenditure of physical activity or following body weight and nutrient intake in healthy subjects and heart rate monitor for protein consumption and recovery in athletes. It should be noted that all the above mentioned methods measuring energy expenditure are useless for establishing threshold levels improving health. For instance in a previous study we demonstrated that walking 12982 daily steps at the acceleration range 0.3-1.0 g had no effect on blood cholesterol, whereas 1062 daily steps at the acceleration range 1.1-2.4 g reduced blood cholesterol by 15% (Vainionischen et al.
- Our invention has many advantages. It makes it possible to determine for the first time the volume and intensity of the physical activity threshold reducing disease risks in subjects, who are sedentary, have overweight and suffer from metabolic disorders. These subjects cover approximately 50% of the population and previously there have not been any physical activity recommendations for them.
- the accelerometer described in the intervention can be easily used continuously making it possible to register all types of physical activity including habitual activities. This will make it easy to meet our novel physical activity recommendations. From the point of preventive medicine walking is also the best form of physical activity. It activates the biggest muscles in the body and its energy expenditure can be accurately measured by accelerometers recording number of steps and step induced accelerations or walking speeds. Maintaining walking ability protects also from falling accidents and hospitalization.
- the results presented in FIG. 1A and 1B are derived from 68 subjects carrying accelerometer for 3 months.
- the subjects were overweight men and women aged 30-70 years and had abnormal blood sugar.
- One half of the subjects participated in supervised exercise weekly and the other half continued their normal life style.
- the subjects carried accelerometers during wake-full time on their waist.
- the acceleration values their daily numbers were continuously registered.
- Blood samples were taken at the beginning and end of the trial to measure blood sugar, insulin, cholesterol, LDL-cholesterol and triglycerides.
- the amount of the visceral fat was measured by a bio-impedance method.
- the distribution of the accelerations during 3 months showed that exercises increased significantly number of steps or impacts in the acceleration classes 0.3-0.7 g, corresponding typically to slow walking 2-3 km/h.
- the steps in the acceleration class 0.3-0.7 were divided by their magnitudes to quartiles. Cholesterol and fat concentrations between each quartile were analyzed. The results showed ( FIG. 1A and 1B ) that total cholesterol, LDL-cholesterol, triglycerides, and visceral fat in the fourth quartile (over 6520 daily steps) were significantly lower than in the other quartiles. 6520 daily steps is the threshold for physical activity, the exceeding of which reduced total cholesterol by 0.6 mmol/l, LDL-cholesterol 0.7 mmol/l, triglycerides 0.4 mmol/l and the area of visceral fat by 12%.
- the invention described herein does essentially differ from the previously known methods by which exercises have been used for prevention of risk factors of diabetes and cardiovascular diseases. Physicians have generally been aware about the beneficial effects of regular exercise, but the volume, intensity and duration of the exercises have been unknown. It was novel and unexpected in our invention that in sedentary subjects physical activity of very low intensity (accelerations 0.3-0.7 g) reduced concentrations of the major risk factors of diabetes and cardiovascular diseases. Our invention is also different form other patents and recommendations, since those do not take low intensity exercise into account.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Physiology (AREA)
- Artificial Intelligence (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Signal Processing (AREA)
- Epidemiology (AREA)
- Fuzzy Systems (AREA)
- Mathematical Physics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Primary Health Care (AREA)
- Evolutionary Computation (AREA)
- Obesity (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20130323 | 2013-11-04 | ||
FI20130323A FI20130323A (sv) | 2013-11-04 | 2013-11-04 | Förfarande för mätning av ett tröskelvärde för motion som främjar fett- och kolesterolmetabolism och minskar mängden fettvävnad hos personer med övervikt eller förhöjd risk för hjärtsjukdom och diabetes |
PCT/FI2014/000031 WO2015063366A1 (en) | 2013-11-04 | 2014-10-31 | Methods and device arrangement for physical activity thresholds promoting fat and cholesterol metabolism in high risk subjects |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FI2014/000031 A-371-Of-International WO2015063366A1 (en) | 2013-11-04 | 2014-10-31 | Methods and device arrangement for physical activity thresholds promoting fat and cholesterol metabolism in high risk subjects |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/438,506 Continuation-In-Part US20190290191A1 (en) | 2013-11-04 | 2019-06-12 | Low impact physical activities for reducing risk of cholesterol and fat metabolism disorders in overweight people |
Publications (1)
Publication Number | Publication Date |
---|---|
US20160283696A1 true US20160283696A1 (en) | 2016-09-29 |
Family
ID=53003410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/034,185 Abandoned US20160283696A1 (en) | 2013-11-04 | 2014-10-31 | Methods and device arrangement for physical activity thresholds promoting fat and cholesterol metabolism in high risk subjects |
Country Status (6)
Country | Link |
---|---|
US (1) | US20160283696A1 (sv) |
EP (1) | EP3065639A4 (sv) |
JP (1) | JP6777543B2 (sv) |
CN (1) | CN106255458A (sv) |
FI (1) | FI20130323A (sv) |
WO (1) | WO2015063366A1 (sv) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019043292A1 (en) * | 2017-08-29 | 2019-03-07 | Gleap Health Technologies Oy | METHODS AND ARRANGEMENT OF THRESHOLD DEVICE OF PHYSICAL ACTIVITY REDUCING THE RISKS OF DIABETES, CARDIOVASCULAR DISEASES, INFLAMMATIONS, DEMENTIA, CANCERS AND MORTALITY IN SEDENTARY SUBJECTS |
WO2020111787A1 (en) * | 2018-11-29 | 2020-06-04 | Samsung Electronics Co., Ltd. | Method for providing recommendations for maintaining a healthy lifestyle basing on daily activity parameters of user, automatically tracked in real time, and corresponding system |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115191961B (zh) * | 2021-04-09 | 2024-08-23 | 广东小天才科技有限公司 | 心肺健康检测方法及装置、可穿戴设备、存储介质 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2229224T3 (es) | 1994-09-07 | 2005-04-16 | Omron Healthcare Co., Ltd. | Dispositivo medidor de una cantidad de ejercicio, capaz de presentar la cantidad de ejercicio que todavia ha de realizarse. |
JP3027346B2 (ja) * | 1997-05-21 | 2000-04-04 | 株式会社スズケン | 運動レベル経時記憶装置 |
US6513532B2 (en) | 2000-01-19 | 2003-02-04 | Healthetech, Inc. | Diet and activity-monitoring device |
FI118951B (sv) | 2004-06-04 | 2008-05-30 | Newtest Oy | Givarenhet, anordningsarrangemang och förfarande som utnyttjar anordningsarrangemanget för att bilda och visa en bedömning av benmassautveckling |
JP4826191B2 (ja) * | 2005-09-27 | 2011-11-30 | パナソニック電工株式会社 | 活動量計 |
JP4830765B2 (ja) * | 2006-09-29 | 2011-12-07 | パナソニック電工株式会社 | 活動量計測システム |
FI20061097A0 (sv) * | 2006-12-11 | 2006-12-11 | Timo Jaakko Jaemsae | Förfarande för att mäta motion som befrämjar kolesterolmetabolism |
JP2008154878A (ja) * | 2006-12-25 | 2008-07-10 | Matsushita Electric Works Ltd | 階段昇降判別装置及び活動量計 |
JP2008246179A (ja) * | 2007-03-30 | 2008-10-16 | Matsushita Electric Works Ltd | 活動量計 |
JP2009022440A (ja) * | 2007-07-18 | 2009-02-05 | Seiko Instruments Inc | ゲームシステム及び運動量測定装置 |
JP5202933B2 (ja) * | 2007-11-30 | 2013-06-05 | 株式会社タニタ | 体動検出装置 |
US7676332B2 (en) | 2007-12-27 | 2010-03-09 | Kersh Risk Management, Inc. | System and method for processing raw activity energy expenditure data |
US9370691B2 (en) * | 2008-03-27 | 2016-06-21 | Polar Electro Oy | Apparatus for metabolic training load, mechanical stimulus, and recovery time calculation |
EP2210557A1 (en) | 2009-01-21 | 2010-07-28 | Koninklijke Philips Electronics N.V. | Determining energy expenditure of a user |
KR20100087551A (ko) * | 2009-01-28 | 2010-08-05 | 한국과학기술연구원 | 사용자의 행동 분류에 따른 칼로리 균형 계산 장치 |
JP5617299B2 (ja) * | 2010-03-25 | 2014-11-05 | オムロンヘルスケア株式会社 | 活動量計、制御プログラムおよび活動種類特定方法 |
US20150324541A1 (en) * | 2011-11-28 | 2015-11-12 | Koninklijke Philips N.V. | Health monitoring system for calculating a total risk score |
CN103027696B (zh) * | 2012-12-06 | 2016-01-06 | 可瑞尔科技(扬州)有限公司 | 人体运动能量消耗仪 |
-
2013
- 2013-11-04 FI FI20130323A patent/FI20130323A/sv not_active Application Discontinuation
-
2014
- 2014-10-31 JP JP2016552701A patent/JP6777543B2/ja active Active
- 2014-10-31 CN CN201480072185.5A patent/CN106255458A/zh active Pending
- 2014-10-31 US US15/034,185 patent/US20160283696A1/en not_active Abandoned
- 2014-10-31 EP EP14857306.6A patent/EP3065639A4/en not_active Withdrawn
- 2014-10-31 WO PCT/FI2014/000031 patent/WO2015063366A1/en active Application Filing
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019043292A1 (en) * | 2017-08-29 | 2019-03-07 | Gleap Health Technologies Oy | METHODS AND ARRANGEMENT OF THRESHOLD DEVICE OF PHYSICAL ACTIVITY REDUCING THE RISKS OF DIABETES, CARDIOVASCULAR DISEASES, INFLAMMATIONS, DEMENTIA, CANCERS AND MORTALITY IN SEDENTARY SUBJECTS |
JP2020531236A (ja) * | 2017-08-29 | 2020-11-05 | グリープ ヘルス テクノロジーズ オーイー | 座りがちな対象の糖尿病、心血管疾患、炎症、認知症、がん、及び死亡率のリスクを軽減する身体活動の閾値に関する方法及び装置の手配 |
JP7336061B2 (ja) | 2017-08-29 | 2023-08-31 | グリープ ヘルス テクノロジーズ オーイー | 座りがちな対象の糖尿病、心血管疾患、炎症、認知症、がん、及び死亡率のリスクを軽減する身体活動の閾値に関する方法及び装置の手配 |
US11804290B2 (en) | 2017-08-29 | 2023-10-31 | Gleap Health Technologies Oy | Methods and device arrangement for physical activity thresholds reducing risks of diabetes, cardiovascular diseases, inflammations, dementia, cancers and mortality in sedentary subjects |
WO2020111787A1 (en) * | 2018-11-29 | 2020-06-04 | Samsung Electronics Co., Ltd. | Method for providing recommendations for maintaining a healthy lifestyle basing on daily activity parameters of user, automatically tracked in real time, and corresponding system |
Also Published As
Publication number | Publication date |
---|---|
FI20130323A (sv) | 2015-05-05 |
JP2016535657A (ja) | 2016-11-17 |
EP3065639A1 (en) | 2016-09-14 |
JP6777543B2 (ja) | 2020-10-28 |
WO2015063366A8 (en) | 2015-09-24 |
WO2015063366A1 (en) | 2015-05-07 |
CN106255458A (zh) | 2016-12-21 |
EP3065639A4 (en) | 2017-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hottenrott et al. | Effects of high intensity training and continuous endurance training on aerobic capacity and body composition in recreationally active runners | |
Uusitalo | Overtraining: making a difficult diagnosis and implementing targeted treatment | |
Lorino et al. | The effects of caffeine on athletic agility | |
Lan et al. | The exercise intensity of tai chi chuan | |
Dunn-Lewis et al. | The effects of a customized over-the-counter mouth guard on neuromuscular force and power production in trained men and women | |
Dolan et al. | The impact of making weight on physiological and cognitive processes in elite jockeys | |
US20160283696A1 (en) | Methods and device arrangement for physical activity thresholds promoting fat and cholesterol metabolism in high risk subjects | |
Yanaoka et al. | A 1-minute Re-warm up at high-intensity improves sprint performance during the Loughborough intermittent shuttle test | |
Driver et al. | Objective assessment of activity in inpatients with traumatic brain injury: initial findings | |
Patel et al. | A study on the effect of Yoga and diet-control on Body mass index and cholesterol level of the Obese Youth | |
Das et al. | The plausible effects of wearing face masks on sports performance–A scoping review | |
US11804290B2 (en) | Methods and device arrangement for physical activity thresholds reducing risks of diabetes, cardiovascular diseases, inflammations, dementia, cancers and mortality in sedentary subjects | |
US20190290191A1 (en) | Low impact physical activities for reducing risk of cholesterol and fat metabolism disorders in overweight people | |
Tiwari et al. | Outcome of breathing exercise (pranayam) on spirometric parameters in type 2 diabetic individuals: a clinical study | |
Fagan | Exploring the Role of Biofeedback in Physiological Monitoring of Alcohol and Caffeine Consumption in Collegiate Softball Athletes | |
Liang et al. | Respiratory patterns and physical fitness in healthy adults: a cross-sectional study | |
Mochizuki et al. | Evaluation of exercise programs at a fitness club in female exercise beginners using anti-aging medical indicators | |
Hoffmann et al. | Starting in your mental pole position: Hypnosis helps elite Downhill Mountainbike athletes to reach their optimal racing mindset | |
JP2020531236A5 (sv) | ||
Brewer | Non-invasive load monitoring in female Division 1 collegiate gymnastics | |
Saravanan | Comparative analysis of body fat among college level footballers from different parts of India | |
Siervo et al. | Validity of some prediction equations to assess resting energy expenditure (REE) in 29 elderly obese subjects (> 60 years) | |
Vakili et al. | The Effect of Combined Training and Vitamin D Supplementation on some Indicators of Liver Damage, Performance and Depression in Women Addicted to Methamphetamine and Heroin. | |
Aziakpono et al. | Alcohol and Glucose D consumption decreases grip muscle strengths in graded doses | |
Franà et al. | RELATIONSHIP OF CARDIORESPIRATORY FITNESS WITH CARDIOVASCULAR RISK FACTORS, PERCEIVED STRESS AND RESPIRATORY FUNCTION IN STREET RUNNING ATHLETES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SARTORIO OY, FINLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LEPPAELUOTO, JUHANI;HERZIG, KARL-HEINZ;AHOLA, RIIKKA;AND OTHERS;SIGNING DATES FROM 20180413 TO 20180417;REEL/FRAME:045816/0628 Owner name: GLEAP HEALTH TECHNOLOGIES OY, FINLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SARTORIO OY;REEL/FRAME:045816/0644 Effective date: 20180417 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |